220 related articles for article (PubMed ID: 32935091)
1. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
Shi PY; Plante J; Liu Y; Liu J; Xia H; Johnson B; Lokugamage K; Zhang X; Muruato A; Zou J; Fontes-Garfias C; Mirchandani D; Scharton D; Kalveram B; Bilello J; Ku Z; An Z; Freiberg A; Menachery V; Xie X; Plante K; Weaver S
Res Sq; 2020 Sep; ():. PubMed ID: 32935091
[TBL] [Abstract][Full Text] [Related]
2. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
bioRxiv; 2020 Sep; ():. PubMed ID: 32908978
[TBL] [Abstract][Full Text] [Related]
3. Spike mutation D614G alters SARS-CoV-2 fitness.
Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671
[TBL] [Abstract][Full Text] [Related]
4. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
[TBL] [Abstract][Full Text] [Related]
5. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
[TBL] [Abstract][Full Text] [Related]
6. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Weissman D; Alameh MG; de Silva T; Collini P; Hornsby H; Brown R; LaBranche CC; Edwards RJ; Sutherland L; Santra S; Mansouri K; Gobeil S; McDanal C; Pardi N; Hengartner N; Lin PJC; Tam Y; Shaw PA; Lewis MG; Boesler C; Şahin U; Acharya P; Haynes BF; Korber B; Montefiori DC
Cell Host Microbe; 2021 Jan; 29(1):23-31.e4. PubMed ID: 33306985
[TBL] [Abstract][Full Text] [Related]
7. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
[TBL] [Abstract][Full Text] [Related]
8. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.
Lee CY; Amrun SN; Chee RS; Goh YS; Mak TM; Octavia S; Yeo NK; Chang ZW; Tay MZ; Torres-Ruesta A; Carissimo G; Poh CM; Fong SW; Bei W; Lee S; Young BE; Tan SY; Leo YS; Lye DC; Lin RT; Maurer-Stroh S; Lee B; Wang CI; Renia L; Ng LF
Clin Transl Immunology; 2021; 10(2):e1241. PubMed ID: 33628442
[TBL] [Abstract][Full Text] [Related]
9. Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020.
Leung K; Pei Y; Leung GM; Lam TT; Wu JT
Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886945
[TBL] [Abstract][Full Text] [Related]
10. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity.
Zhang L; Jackson CB; Mou H; Ojha A; Rangarajan ES; Izard T; Farzan M; Choe H
bioRxiv; 2020 Jun; ():. PubMed ID: 32587973
[TBL] [Abstract][Full Text] [Related]
11. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
12. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Zhang L; Jackson CB; Mou H; Ojha A; Peng H; Quinlan BD; Rangarajan ES; Pan A; Vanderheiden A; Suthar MS; Li W; Izard T; Rader C; Farzan M; Choe H
Nat Commun; 2020 Nov; 11(1):6013. PubMed ID: 33243994
[TBL] [Abstract][Full Text] [Related]
14. Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE.
Juma KM; Morimoto K; Sharma V; Sharma K; Biyani R; Biyani M; Takita T; Yasukawa K
Mol Biol Rep; 2024 Feb; 51(1):289. PubMed ID: 38329653
[TBL] [Abstract][Full Text] [Related]
15. D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity.
Bhattacharya M; Chatterjee S; Sharma AR; Agoramoorthy G; Chakraborty C
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9035-9045. PubMed ID: 34755213
[TBL] [Abstract][Full Text] [Related]
16. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.
von Bartheld CS; Hagen MM; Butowt R
ACS Chem Neurosci; 2021 Oct; 12(19):3535-3549. PubMed ID: 34533304
[TBL] [Abstract][Full Text] [Related]
17. The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.
Bamberger C; Pankow S; Martínez-Bartolomé S; Diedrich J; Park R; Yates J
bioRxiv; 2021 Feb; ():. PubMed ID: 33619478
[TBL] [Abstract][Full Text] [Related]
18. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
[TBL] [Abstract][Full Text] [Related]
19. Making sense of spike D614G in SARS-CoV-2 transmission.
Shi AC; Xie X
Sci China Life Sci; 2021 Jul; 64(7):1062-1067. PubMed ID: 33587268
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W
J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
